Fluorouracil Cream 0.5% for Actinic Keratoses on Multiple Body Sites: An 18-Month Open-Label Study

Article Type
Article
Changed
Thu, 01/10/2019 - 12:20
Display Headline
Fluorouracil Cream 0.5% for Actinic Keratoses on Multiple Body Sites: An 18-Month Open-Label Study
Author(s)
Stough D
Bucko AD
Vamvakias G
Rafal ES
Davis SA

Article PDF
085050267.pdf
Author and Disclosure Information

Stough D, Bucko AD, Vamvakias G, Rafal ES, Davis SA

Issue
Cutis - 85(5)
Publications
Cutis
MDedge Dermatology
Topics
Actinic Keratosis
Page Number
267-273
Sections
Original Research
Author(s)
Stough D
Bucko AD
Vamvakias G
Rafal ES
Davis SA
Author(s)
Stough D
Bucko AD
Vamvakias G
Rafal ES
Davis SA
Author and Disclosure Information

Stough D, Bucko AD, Vamvakias G, Rafal ES, Davis SA

Author and Disclosure Information

Stough D, Bucko AD, Vamvakias G, Rafal ES, Davis SA

Article PDF
085050267.pdf
Article PDF
085050267.pdf

Issue
Cutis - 85(5)
Issue
Cutis - 85(5)
Page Number
267-273
Page Number
267-273
Publications
Cutis
MDedge Dermatology
Publications
Cutis
MDedge Dermatology
Topics
Actinic Keratosis
Article Type
Article
Display Headline
Fluorouracil Cream 0.5% for Actinic Keratoses on Multiple Body Sites: An 18-Month Open-Label Study
Display Headline
Fluorouracil Cream 0.5% for Actinic Keratoses on Multiple Body Sites: An 18-Month Open-Label Study
Sections
Original Research
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Safety of a Novel Gel Formulation of Clindamycin Phosphate 1.2%–Tretinoin 0.025%: Results From a 52-Week Open-Label Study

Article Type
Article
Changed
Thu, 01/10/2019 - 12:16
Display Headline
Safety of a Novel Gel Formulation of Clindamycin Phosphate 1.2%–Tretinoin 0.025%: Results From a 52-Week Open-Label Study
Author(s)
Kircik LH
Peredo MI
Bucko AD
Loss Rw Jr
Fowler Jf Jr
Wortzman M
Neumaier GJ

Article PDF
082050358.pdf
Author and Disclosure Information

Kircik LH, Peredo MI, Bucko AD, Loss RW Jr, Fowler JF Jr, Wortzman M, Neumaier GJ

Issue
Cutis - 82(5)
Publications
Cutis
MDedge Dermatology
Topics
Acne
Page Number
358-366
Sections
Original Research
Author(s)
Kircik LH
Peredo MI
Bucko AD
Loss Rw Jr
Fowler Jf Jr
Wortzman M
Neumaier GJ
Author(s)
Kircik LH
Peredo MI
Bucko AD
Loss Rw Jr
Fowler Jf Jr
Wortzman M
Neumaier GJ
Author and Disclosure Information

Kircik LH, Peredo MI, Bucko AD, Loss RW Jr, Fowler JF Jr, Wortzman M, Neumaier GJ

Author and Disclosure Information

Kircik LH, Peredo MI, Bucko AD, Loss RW Jr, Fowler JF Jr, Wortzman M, Neumaier GJ

Article PDF
082050358.pdf
Article PDF
082050358.pdf

Issue
Cutis - 82(5)
Issue
Cutis - 82(5)
Page Number
358-366
Page Number
358-366
Publications
Cutis
MDedge Dermatology
Publications
Cutis
MDedge Dermatology
Topics
Acne
Article Type
Article
Display Headline
Safety of a Novel Gel Formulation of Clindamycin Phosphate 1.2%–Tretinoin 0.025%: Results From a 52-Week Open-Label Study
Display Headline
Safety of a Novel Gel Formulation of Clindamycin Phosphate 1.2%–Tretinoin 0.025%: Results From a 52-Week Open-Label Study
Sections
Original Research
Article Source

PURLs Copyright

Inside the Article

Article PDF Media
Subscribe to Bucko AD